Clinical trial
A Multi-centre, Prospective, Observational Study Evaluating Whether Integration of Prognostic and Predictive Algorithms Into Routine Clinical Practice Effect Whether Oncologists Order Multigene Assays in Patients With Early Stage Breast Cancer
NCT04131933 is registered in ClinicalTrials.gov with Ottawa Hospital Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-centre, Prospective, Observational Study Evaluating Whether Integration of Prognostic and Predictive Algorithms Into Routine Clinical Practice Effect Whether Oncologists Order Multigene Assays in Patients With Early Stage Breast Cancer
- Lead sponsor
- Ottawa Hospital Research Institute
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 6, 2020
- Completion date
- May 18, 2022
- Enrollment
- 602 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer